Skip to content

Voluntary Medical Male Circumcision for Reducing HIV Risk among MSM: a Feasibility Intervention Trial

Voluntary Medical Male Circumcision for Reducing HIV Risk among MSM: a Feasibility Intervention Trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039436
Enrollment
Unknown
Registered
2020-10-28
Start date
2020-11-01
Completion date
Unknown
Last updated
2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acquired Immunodeficiency Syndrome,AIDS

Interventions

Intervention group:Voluntary Medical Male Circumcision
Control group:N/A

Sponsors

School of Public Health (Shenzhen), Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 49 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-49 years; 2. Physiological male, had male-male sex in the past 6 months; 3. Had at least 7 times insertive anal sex in the recent 10 male sex; 4. Rapid HIV screening and laboratory serological test negative; 5. Willing to actually uptake circumcision; 6. Self-reported foreskins coverage more than half of the glans when the penis is not erect; 7. Live in the city where the research site is located, and have no plans to migrate to another city in the next year; 8. Willing to be allocated to one of the two groups (intervention group or control group) before randomization; 9. Willing to accept blood sampling and exfoliated penile cell sampling for HIV, HSV-2, syphilis and penile HPV testing; 10. Willing to sign an informed consent form before participating in the circumcision intervention trial.

Exclusion criteria

Exclusion criteria: Research subjects who meet any of the following criteria will be excluded: 1. Have done circumcision surgery; 2. Participate in other biomedical intervention research which aims at preventing HIV infection at the same time; 3. Have been suffered from hemophilia or other bleeding disorders; 4. Contraindications for circumcision surgery.

Design outcomes

Primary

MeasureTime frame
HIV incidence;

Secondary

MeasureTime frame
HSV-2 prevalence, incidence;Syphilis prevalence, incidence rate;HPV prevalence, incidence rate in penis;

Countries

China

Contacts

Public ContactHuachun Zou

School of Public Health (Shenzhen), Sun Yat-Sen University

zouhuachun@mail.sysu.edu.cn+86 13926420419

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026